We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

64 hedge funds and large institutions have $245M invested in Heron Therapeutics in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,470% more call options, than puts

Call options by funds: $957K | Put options by funds: $10K

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

22% more capital invested

Capital invested by funds: $202M → $245M (+$43.8M)

8% more funds holding

Funds holding: 59 → 64 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
64
Holders Change
+5
Holders Change %
+8.47%
% of All Funds
1.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
25
Reduced
9
Closed
8
Calls
$957K
Puts
$10K
Net Calls
+$947K
Net Calls Change
+$947K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.16M
2
Franklin Resources
Franklin Resources
California
+$1.97M
3
KCM
Kingdon Capital Management
New York
+$1.41M
4
RA
Royce & Associates
New York
+$1.39M
5
BFA
BlackRock Fund Advisors
California
+$809K

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$3.12M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.42M
3
EA
Emerald Advisers
Pennsylvania
-$2.41M
4
PA
Perceptive Advisors
New York
-$1.79M
5
FM
Forward Management
California
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Turner Investments
Pennsylvania
$806K -$356K -43,650 -35%
TCIM
27
TIAA CREF Investment Management
New York
$768K +$26.2K +3,211 +4%
BIM
28
BlackRock Investment Management
Delaware
$667K +$3.27K +400 +0.6%
ACA
29
Avoro Capital Advisors
New York
$663K +$538K +65,900 New
ECM
30
Endurant Capital Management
California
$584K +$474K +58,100 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$460K +$373K +45,678 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$432K +$1.5K +184 +0.4%
Charles Schwab
33
Charles Schwab
California
$410K – – –
TA
34
Teachers Advisors
New York
$318K +$45.5K +5,572 +21%
MLICM
35
Metropolitan Life Insurance Company (MetLife)
New York
$231K – – –
Morgan Stanley
36
Morgan Stanley
New York
$217K +$146K +17,872 +478%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$197K +$160K +19,610 New
NFA
38
Nationwide Fund Advisors
Ohio
$177K – – –
JP Morgan Chase
39
JP Morgan Chase
New York
$176K +$143K +17,469 New
VOYA Investment Management
40
VOYA Investment Management
Georgia
$174K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$165K +$4.69K +575 +4%
AIG
42
American International Group
New York
$147K +$15.4K +1,886 +15%
Group One Trading
43
Group One Trading
Illinois
$134K +$102K +12,447 +1,383%
Citadel Advisors
44
Citadel Advisors
Florida
$131K +$107K +13,054 New
BA
45
BlackRock Advisors
Delaware
$108K +$12.2K +1,490 +16%
EA
46
Emerald Advisers
Pennsylvania
$104K -$2.41M -295,550 -97%
Prudential Financial
47
Prudential Financial
New Jersey
$104K +$84.1K +10,300 New
Citigroup
48
Citigroup
New York
$64K +$45.1K +5,528 +653%
JAM
49
JW Asset Management
Florida
$33K +$26.7K +3,275 New
Barclays
50
Barclays
United Kingdom
$19K +$9.2K +1,127 +147%
1
2
3

HRTX Hedge Fund Activity: Q4 2014 in Review

64 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2014, worth a combined $245M — up 22% from $202M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new HRTX positions and 8 closed out — a net gain of 6 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.16M. The largest seller was Federated Hermes, exiting entirely with an estimated $3.12M sold.

  • 64 institutional investors held Heron Therapeutics (HRTX) as of Q4 2014, up from 59 in Q3 2014.
  • Funds reported $245M of Heron Therapeutics stock for Q4 2014, up 22% quarter-over-quarter.
  • 14 funds opened new Heron Therapeutics positions in Q4 2014 and 8 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2014 was Point72 Asset Management, an estimated $4.16M added.
  • The largest Heron Therapeutics seller in Q4 2014 was Federated Hermes, an estimated $3.12M sold.

Based on aggregated 13F filings for Q4 2014.